Literature DB >> 18077755

Family practice patients' adherence to statin medications.

Nandini Natarajan1, R Wayne Putnam, Alexandra M Yip, Dawn Frail.   

Abstract

OBJECTIVE: To measure family practice patients' adherence to statin medications and to identify factors associated with adherence to these medications.
DESIGN: Cross-sectional study using a mailed self-report survey sent to 400 patients.
SETTING: Two academic family practice clinics in Halifax, NS. PARTICIPANTS: A total of 284 patients aged 40 or older who were prescribed statin medications by their family physicians, either for the first time or as a renewal during a 20-month period. MAIN OUTCOME MEASURES: Level of adherence to statin medications as measured by patients' self-report on the Morisky scale; association between high adherence on the Morisky scale and 38 patient-reported factors.
RESULTS: Response rate was 82.5%. Average age of patients was 65 years, 57% were men, 62% had been on statin medications for more than 2 years, and 97% reported that their family physicians managed their cholesterol levels. More than 63% of patients reported high adherence as measured by the Morisky scale. On multiple logistic regression, being older than 65, taking 4 to 6 other prescribed medications, and having a lifestyle that included regular exercise or a healthy diet were significant independent predictors of high adherence scores on the Morisky scale.
CONCLUSION: Almost two-thirds (63%) of patients who were prescribed statins by their family physicians reported high adherence to the medications. Strategies to improve adherence would best be directed at patients who are younger or taking fewer than 4 or more than 6 other prescribed medications. Patients should be encouraged to maintain a lifestyle of regular exercise and a healthy diet, as this was associated with better adherence to statin medications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18077755      PMCID: PMC2231556     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  32 in total

1.  Determinants of discontinuation of new courses of antihypertensive medications.

Authors:  Jean-Pierre Grégoire; Jocelyne Moisan; Rémi Guibert; Antonio Ciampi; Alain Milot; Michel Gaudet; Isabelle Côté
Journal:  J Clin Epidemiol       Date:  2002-07       Impact factor: 6.437

2.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

3.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Authors: 
Journal:  Lancet       Date:  1994-11-19       Impact factor: 79.321

4.  Suboptimal statin adherence and discontinuation in primary and secondary prevention populations.

Authors:  Jeffrey J Ellis; Steven R Erickson; James G Stevenson; Steven J Bernstein; Renee A Stiles; A Mark Fendrick
Journal:  J Gen Intern Med       Date:  2004-06       Impact factor: 5.128

5.  Concurrent and predictive validity of a self-reported measure of medication adherence.

Authors:  D E Morisky; L W Green; D M Levine
Journal:  Med Care       Date:  1986-01       Impact factor: 2.983

6.  Medication adherence and associated hemoglobin A1c in type 2 diabetes.

Authors:  Kimberley Krapek; Kathleen King; Susan S Warren; Karen G George; Dorothy A Caputo; Karen Mihelich; Elizabeth M Holst; Michael B Nichol; Sheng G Shi; Kevin B Livengood; Steve Walden; Teresa J Lubowski
Journal:  Ann Pharmacother       Date:  2004-07-06       Impact factor: 3.154

7.  Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study.

Authors:  L Wei; J Wang; P Thompson; S Wong; A D Struthers; T M MacDonald
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

Review 8.  Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients.

Authors:  Marie Krousel-Wood; Sheila Thomas; Paul Muntner; Donald Morisky
Journal:  Curr Opin Cardiol       Date:  2004-07       Impact factor: 2.161

9.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

10.  Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study.

Authors:  Carmen Turbí; Gabriel Herrero-Beaumont; Juan Carlos Acebes; Antonio Torrijos; Jenaro Graña; Roberto Miguélez; JoséAntonio Sacristán; Fernando Marín
Journal:  Clin Ther       Date:  2004-02       Impact factor: 3.393

View more
  13 in total

1.  Achievement of LDL Cholesterol Goal and Adherence to Statin by Diabetes Patients in Kelantan.

Authors:  Zainab Mat Yudin; Lili Husniati Yaacob; Norul Badriah Hassan; Saiful Bahari Ismail; Nani Draman; Siti Suhaila Mohd Yusoff
Journal:  Malays J Med Sci       Date:  2017-06-30

2.  Lipid-lowering drugs as primary prevention in general practice: do patients reach guideline goals and continue treatment? ADDITION Denmark.

Authors:  Lise Graversen; Bo Christensen; Knut Borch-Johnsen; Torsten Lauritzen; Annelli Sandbaek
Journal:  Scand J Prim Health Care       Date:  2011-12       Impact factor: 2.581

3.  The Aston Medication Adherence Study: mapping the adherence patterns of an inner-city population.

Authors:  Christopher A Langley; Joseph Bush
Journal:  Int J Clin Pharm       Date:  2013-12-01

4.  Possible association of ABCB1:c.3435T>C polymorphism with high-density-lipoprotein-cholesterol response to statin treatment--a pilot study.

Authors:  Anna Sałacka; Agnieszka Bińczak-Kuleta; Mariusz Kaczmarczyk; Iwona Hornowska; Krzysztof Safranow; Jeremy S C Clark
Journal:  Bosn J Basic Med Sci       Date:  2014-08-14       Impact factor: 3.363

5.  Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities.

Authors:  Heli Halava; Maarit Jaana Korhonen; Risto Huupponen; Soko Setoguchi; Jaana Pentti; Mika Kivimäki; Jussi Vahtera
Journal:  CMAJ       Date:  2014-06-23       Impact factor: 8.262

6.  Barriers to Treatment and Control of Hypertension among Hypertensive Participants: A Community-Based Cross-sectional Mixed Method Study in Municipalities of Kathmandu, Nepal.

Authors:  Surya Devkota; Raja Ram Dhungana; Achyut Raj Pandey; Bihungum Bista; Savyata Panthi; Kartikesh Kumar Thakur; Ratna Mani Gajurel
Journal:  Front Cardiovasc Med       Date:  2016-08-02

7.  Adherence to lipid-lowering treatment: the patient perspective.

Authors:  Manuela Casula; Elena Tragni; Alberico Luigi Catapano
Journal:  Patient Prefer Adherence       Date:  2012-11-08       Impact factor: 2.711

8.  Association of Weight Loss and Medication Adherence Among Adults With Type 2 Diabetes Mellitus: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes).

Authors:  Susan Grandy; Kathleen M Fox; Elise Hardy
Journal:  Curr Ther Res Clin Exp       Date:  2013-12

9.  Predictors of first-year statin medication discontinuation: A cohort study.

Authors:  Heli Halava; Risto Huupponen; Jaana Pentti; Mika Kivimäki; Jussi Vahtera
Journal:  J Clin Lipidol       Date:  2016-05-06       Impact factor: 4.766

10.  Potential contribution of lifestyle and socioeconomic factors to healthy user bias in antihypertensives and lipid-lowering drugs.

Authors:  Mitsuyo Kinjo; Edward Chia-Cheng Lai; Maarit Jaana Korhonen; Rita L McGill; Soko Setoguchi
Journal:  Open Heart       Date:  2017-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.